Why the study?
Does the choice of anesthetic (etomidate, propofol, or thiopental) alter cardiovascular effects in patients undergoing electroconvulsive therapy?
Does the choice of anesthetic (etomidate, propofol, or thiopental) alter cardiovascular effects in patients undergoing electroconvulsive therapy?
Etomidate, propofol, and thiopental produce similar acute cardiovascular changes (blood pressure and heart rate) during electroconvulsive therapy.
Answers are grounded in this paper and cite their sources.
Any of these agents may be chosen for ECT without differential cardiovascular concern; confirms hemodynamic equivalence in this RCT.
Cardiovascular alterations during electroconvulsive therapy (ECT) are a major concern for this treatment. Although several studies have been performed to compare the effects of anesthetics on these alterations, the results are mixed and doubt still exists regarding the choice of the best drug. We conducted a randomized, double-blind clinical trial to compare the effects of 3 anesthetics used in ECT: etomidate, propofol, and thiopental. Patients (N=30) were randomized to receive one of these drugs as the anesthetic for the ECT procedure. Cardiovascular evaluation consisted of the measurement of blood systolic and diastolic pressure and heart rate before and immediately after the end of the seizure for each patient during a course of ECT. The results showed that etomidate, propofol, and thiopental were associated with similar cardiovascular effects.
No takes yet. Share an insight, caveat, or question.
Rosa et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: